Literature DB >> 24080496

Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.

Chee Thum1, Ehab A Husain, Kathleen Mulholland, Jason L Hornick, Thomas Brenn.   

Abstract

Atypical fibroxanthoma and pleomorphic dermal sarcoma may be difficult to separate from cutaneous angiosarcoma. We aim to study the morphological spectrum of pseudoangiomatous features in these tumors and the value of staining for endothelial markers CD31, CD34, FLI1, and ERG. Eleven atypical fibroxanthomas and 3 pleomorphic dermal sarcomas were identified. All tumors arose on sun-damaged skin of elderly men. Atypical fibroxanthomas were nodular and confined to the dermis, whereas pleomorphic dermal sarcoma invaded into underlying fascia. All tumors were composed of pleomorphic epithelioid and spindle cells showing blood-filled spaces and intratumoral hemorrhage. Intracytoplasmic vacuoles (n = 4), hemosiderin deposition (n = 2), and keloidal stromal change (n = 1) were also noted. Immunohistochemically, CD31 was expressed in 43% of cases, FLI1 in 79% and smooth muscle actin in 50%. Staining for CD34, ERG, S100, HMB-45, desmin, p63 and cytokeratins was negative. Follow up (median, 43.1 months; range 1-100), available for 10 patients, showed no adverse outcome. Pseudoangiomatous features and aberrant expression of CD31 and FLI1 in atypical fibroxanthoma and pleomorphic dermal sarcoma may lead to an erroneous diagnosis of cutaneous angiosarcoma. Negativity for CD34 and ERG, in particular, is a reliable differentiating feature in this setting.
© 2013.

Entities:  

Keywords:  AFX; Atypical fibroxanthoma; Cutaneous angiosarcoma; Immunohistochemistry; Pleomorphic dermal sarcoma

Mesh:

Substances:

Year:  2013        PMID: 24080496     DOI: 10.1016/j.anndiagpath.2013.08.004

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  7 in total

Review 1.  [Cutaneous angiosarcoma: new aspects].

Authors:  T Brenn
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

2.  Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.

Authors:  Banafsheh Nazari; Lisa M Rice; Giuseppina Stifano; Alexander M S Barron; Yu Mei Wang; Tess Korndorf; Jungeun Lee; Jag Bhawan; Robert Lafyatis; Jeffrey L Browning
Journal:  Am J Pathol       Date:  2016-08-23       Impact factor: 4.307

Review 3.  Soft Tissue Special Issue: Cutaneous Pleomorphic Spindle Cell Tumors.

Authors:  Thomas Brenn
Journal:  Head Neck Pathol       Date:  2020-01-16

Review 4.  Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.

Authors:  Teo Soleymani; S Tyler Hollmig
Journal:  Curr Treat Options Oncol       Date:  2017-08

5.  Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data.

Authors:  Mathias Ørholt; Frederik L Aaberg; Kiya Abebe; S Walsh; Randall K Roenigk; Alessandro Venzo; Grethe Schmidt; Helle Klyver; David H Jensen; Mikkel Herly; Peter V Vester-Glowinski
Journal:  J Surg Oncol       Date:  2022-04-19       Impact factor: 2.885

Review 6.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08

7.  Dermoscopic rainbow pattern: A clue to diagnosing aneurysmal atypical fibroxanthoma.

Authors:  Michael Kunz; Helena Svensson; John Paoli
Journal:  JAAD Case Rep       Date:  2018-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.